Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals ... Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in …
US FDA approves Regeneron's blood cancer therapy | Reuters
Jul 2, 2025 · Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood cancer called multiple myeloma that …
Press Releases | Regeneron Investors
Jun 7, 2025 · Discover insights into Regeneron's press releases and other key information relevant for investors.
Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood …
Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.
PUSH THE BOUNDS OF SCIENCE - Regeneron
Regeneron is a leading biotechnology company dedicated to inventing, developing and commercializing life-transforming medicines for people with serious diseases.
US FDA approves Regeneron's blood cancer therapy - MSN
By Puyaan Singh (Reuters) -Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood cancer called multiple myeloma …
Regeneron Pharmaceuticals (REGN) Stock Price & Overview
2 days ago · A detailed overview of Regeneron Pharmaceuticals, Inc. (REGN) stock, including real-time price, chart, key statistics, news, and more.
About Regeneron | Our Company
Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, …
Regeneron hiring Medical Specialist I - Ann Arbor, MI - LinkedIn
Does this sound like you? Apply now to take your first step towards living the Regeneron Way!